AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32244890 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) assessed using the Godin-Shephard Leisure-Time Exercise Questionnaire (GSLTPAQ)
Number of subjects: 275
Study 32244890 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure-time activity assessed using the Physical Activity Questionnaire for Older Children (PAQ-C)
Number of subjects: 275
Study 32244890 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 275
Study 32244890 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen time
Number of subjects: 275
Study 32244890 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels
Number of subjects: 275
Study 36122378 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised online yoga program (12 weeks, 1 video per week, performed 3 times per week)
Number of subjects: 212
Study 36122378 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised online yoga program
Number of subjects: 212
Study 36122378 — intervention group
Group type: COMPARATOR
Intervention: Control (online osteoarthritis information)
Number of subjects: 212
Study 36464887 — intervention group
Group type: EXPERIMENTAL
Intervention: Single ambulatory phlebectomy (SAP)
Number of subjects: 464
Study 36464887 — intervention group
Group type: COMPARATOR
Intervention: Saphenous thermal ablation with concomitant phlebectomy (TAP)
Number of subjects: 464
Study 34297719 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed information about the centre and a free entry pass
Number of subjects: 1320
Study 34297719 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal intervention supplemented by customer relations management support
Number of subjects: 1320
Study 34297719 — intervention group
Group type: COMPARATOR
Intervention: Control condition (public awareness raising)
Number of subjects: 1320
Study 34435795 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 641
Study 34435795 — intervention group
Group type: COMPARATOR
Intervention: Standard patient interactions
Number of subjects: 641
Study 33160420 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS-assisted cognitive training with anodal tDCS over left DLPFC
Number of subjects: 46
Study 33160420 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training plus sham stimulation
Number of subjects: 46
Study 33160420 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS-assisted cognitive training
Number of subjects: 46
Study 36181015 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg then 4 mg/kg/h)
Number of subjects: 68
Study 36181015 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 68
Study 33430839 — intervention group
Group type: EXPERIMENTAL
Intervention: IlluminOss® Photodynamic Bone Stabilization System
Number of subjects: 12
Study 35115099 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4330
Study 33825411 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoheal cream
Number of subjects: 52
Study 33825411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 33385203 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-target glucose control
Number of subjects: 1476
Study 33385203 — intervention group
Group type: COMPARATOR
Intervention: Higher-target glucose control
Number of subjects: 1476
Study 33110042 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D (400 IU of 25-hydroxyvitamin-D and 1,000 mg of calcium per day)
Number of subjects: 20050
Study 33110042 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 20050
Study 32016523 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic parameters (snoring index, percentage snoring time, sound pressure level, sound energy, loudness, psychoacoustic annoyance, psychoacoustic snore score) measured during treatment.
Number of subjects: 18
Study 32016523 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean sound energy LAeq over the entire night after intervention.
Number of subjects: 18
Study 32016523 — intervention group
Group type: COMPARATOR
Intervention: Control night measurements (not specified).
Number of subjects: 18
Study 33211672 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 6201
Study 33211672 — intervention group
Group type: COMPARATOR
Intervention: No BCG vaccination (Control)
Number of subjects: 6201
Study 32216138 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 26
Study 32216138 — intervention group
Group type: COMPARATOR
Intervention: DBT + DBT Prolonged Exposure (DBT PE)
Number of subjects: 26
Study 36062574 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Treatment Group (ITG)
Number of subjects: 75
Study 36062574 — intervention group
Group type: COMPARATOR
Intervention: Later Treatment Group (LTG)
Number of subjects: 75
Study 36062574 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ITG and LTG)
Number of subjects: 75
Study 34462278 — intervention group
Group type: EXPERIMENTAL
Intervention: New Nordic Renal Diet (NNRD) with a dietary phosphorus intake reduction to 850 mg/day
Number of subjects: 60
Study 34462278 — intervention group
Group type: COMPARATOR
Intervention: Non-restricted habitual diet
Number of subjects: 60
Study 34462278 — intervention group
Group type: EXPERIMENTAL
Intervention: New Nordic Renal Diet (NNRD)
Number of subjects: 60
Study 32220893 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV) plus 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX) and 5-fluorouracil/leucovorin/irinotecan (FOLFIRI)
Number of subjects: 280
Study 32220893 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of post-induction mAF and post-induction mean mutant molecules per milliliter (mMMPM)
Number of subjects: 280
Study 32220893 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in ctDNA (stratified by a 10-fold or 100-fold reduction in mAF between pre- and post-induction plasma)
Number of subjects: 280
Study 32220893 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-induction mAF and mMMPM
Number of subjects: 280
Study 35600332 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM decoction combined with acupuncture and moxibustion (A&M) treatment based on syndrome differentiation and treatment (SDT)
Number of subjects: 0
Study 35600332 — intervention group
Group type: COMPARATOR
Intervention: Conventional cardiac rehabilitation (CCR)
Number of subjects: 0
Study 35600332 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM decoction combined with A&M
Number of subjects: 0
Study 34687869 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson relaxation (BR)
Number of subjects: 120
Study 34687869 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 120
Study 34455804 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolate treatments (Sclerotinia sclerotiorum) on fruit inoculation
Number of subjects: 3
Study 34455804 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolate treatments (Sclerotinia sclerotiorum) on petiole inoculation
Number of subjects: 3
Study 34455804 — intervention group
Group type: COMPARATOR
Intervention: Mock-inoculated controls (PDA plug only) on fruit
Number of subjects: 3
Study 34455804 — intervention group
Group type: COMPARATOR
Intervention: Mock-inoculated controls (sterile PDA) on petioles
Number of subjects: 3
Study 34455804 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of stem rot susceptibility among four cultivars
Number of subjects: 3
Study 34599925 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention (healthy school lunch-box)
Number of subjects: 742
Study 34599925 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (150 min of planned in-school physical activity)
Number of subjects: 742
Study 34599925 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical activity and nutrition
Number of subjects: 742
Study 34599925 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 742
Study 32954762 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency treatment of suprascapular and axillary nerves
Number of subjects: 20
Study 32954762 — intervention group
Group type: COMPARATOR
Intervention: Nerve block treatment of suprascapular and axillary nerves
Number of subjects: 20
Study 32954762 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency treatment
Number of subjects: 20
Study 32954762 — intervention group
Group type: COMPARATOR
Intervention: Nerve block treatment
Number of subjects: 20
Study 35648636 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-Focused Skills Training (EFST) - experiential condition (n = 120)
Number of subjects: 236
Study 35648636 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational only condition (n = 116)
Number of subjects: 236
Study 33186735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral autoregulation monitoring for MAP targets during CPB
Number of subjects: 460
Study 33186735 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 460
Study 35587063 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide-based triple therapy (nitazoxanide, proton pump inhibitor, and clarithromycin) for 14 days
Number of subjects: 100
Study 35587063 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole-based standard treatment (metronidazole, omeprazole, and clarithromycin) for 14 days
Number of subjects: 100
Study 35587063 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide-based triple therapy
Number of subjects: 100
Study 34792396 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 × 45-min educational sessions based on the Multi-Theory Model
Number of subjects: 80
Study 34792396 — intervention group
Group type: COMPARATOR
Intervention: Health advice (Control)
Number of subjects: 80
Study 33579203 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score (GRS) calculated from 22 CRC risk-associated SNPs
Number of subjects: 1769
Study 33579203 — intervention group
Group type: EXPERIMENTAL
Intervention: GRS categories: low (< 0.5), average (0.5–1.5), elevated (> 1.5)
Number of subjects: 1769
Study 33579203 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher GRS
Number of subjects: 1769
Study 33579203 — intervention group
Group type: COMPARATOR
Intervention: Positive family history
Number of subjects: 1769
Study 32030454 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation (100% lavender oil for 3 minutes)
Number of subjects: 126
Study 32030454 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prior application)
Number of subjects: 126
Study 36203135 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of smartphone application and fitness bracelet for 3 months alongside brief lifestyle counselling.
Number of subjects: 160
Study 36203135 — intervention group
Group type: COMPARATOR
Intervention: Brief lifestyle counselling alone (Control Group).
Number of subjects: 160
Study 32301671 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR laser at 2.4 J/cm2
Number of subjects: 30
Study 32301671 — intervention group
Group type: EXPERIMENTAL
Intervention: red+NIR laser at 2.4 J/cm2
Number of subjects: 30
Study 32301671 — intervention group
Group type: COMPARATOR
Intervention: red laser at 0.6 J/cm2
Number of subjects: 30
Study 32301671 — intervention group
Group type: COMPARATOR
Intervention: red+NIR lasers at 0.6 J/cm2
Number of subjects: 30
Study 32301671 — intervention group
Group type: COMPARATOR
Intervention: red+NIR lasers at 1.2 J/cm2
Number of subjects: 30
Study 32301671 — intervention group
Group type: COMPARATOR
Intervention: red+NIR lasers at 2.4 J/cm2
Number of subjects: 30
Study 32301671 — intervention group
Group type: EXPERIMENTAL
Intervention: red laser at 2.4 J/cm2
Number of subjects: 30
Study 35462552 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel + carboplatin (group A1)
Number of subjects: 66
Study 35462552 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin + carboplatin (A2)
Number of subjects: 66
Study 35462552 — intervention group
Group type: COMPARATOR
Intervention: Eribulin + cyclophosphamide (B1)
Number of subjects: 66
Study 35462552 — intervention group
Group type: COMPARATOR
Intervention: Eribulin + capecitabine (B2)
Number of subjects: 66
Study 32896692 — intervention group
Group type: EXPERIMENTAL
Intervention: MSK-HQ
Number of subjects: 524
Study 32896692 — intervention group
Group type: COMPARATOR
Intervention: EQ-5D-5L
Number of subjects: 524
Study 32896692 — intervention group
Group type: COMPARATOR
Intervention: site-specific PROMs
Number of subjects: 524
Study 32896692 — intervention group
Group type: COMPARATOR
Intervention: SF-12
Number of subjects: 524
Study 35226221 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA-guided ICA (n = 115)
Number of subjects: 220
Study 35226221 — intervention group
Group type: COMPARATOR
Intervention: NIST-guided ICA (n = 105)
Number of subjects: 220
Study 33284944 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Number of subjects: 28
Study 34048073 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal health education session (PHES)
Number of subjects: 50
Study 34048073 — intervention group
Group type: COMPARATOR
Intervention: Standard oral hygiene education (control group)
Number of subjects: 50
Study 33160161 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG intervention group
Number of subjects: 100
Study 33160161 — intervention group
Group type: COMPARATOR
Intervention: Control group (biomass)
Number of subjects: 100
Study 32678998 — intervention group
Group type: EXPERIMENTAL
Intervention: Manualised psychological treatment for tinnitus, details on dosage and duration not specified.
Number of subjects: 9
Study 32678998 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group).
Number of subjects: 9
Study 34982954 — intervention group
Group type: COMPARATOR
Intervention: Reading comprehension measures (DS group)
Number of subjects: 38
Study 34982954 — intervention group
Group type: COMPARATOR
Intervention: Listening comprehension measures (DS group)
Number of subjects: 38
Study 34143220 — intervention group
Group type: EXPERIMENTAL
Intervention: HPactive
Number of subjects: 22
Study 34143220 — intervention group
Group type: COMPARATOR
Intervention: HPpassive
Number of subjects: 22
Study 35468589 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing (6 breaths/min)
Number of subjects: 67
Study 35468589 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced breathing (12 breaths/min)
Number of subjects: 67
Study 35468589 — intervention group
Group type: COMPARATOR
Intervention: Control group (no instructions)
Number of subjects: 67
Study 34294137 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐paced walking with real‐time feedback
Number of subjects: 30
Study 34294137 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐paced walking
Number of subjects: 30
Study 34294137 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐paced walking with an internal focus of attention
Number of subjects: 30
Study 34294137 — intervention group
Group type: EXPERIMENTAL
Intervention: speed-matched walking
Number of subjects: 30
Study 35687187 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 180
Study 35687187 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 180
Study 34769797 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Aerobic Training (CAT)
Number of subjects: 87
Study 34769797 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Aerobic Training (IAT)
Number of subjects: 87
Study 34769797 — intervention group
Group type: COMPARATOR
Intervention: Non-training Control Group (CG)
Number of subjects: 87
Study 32300362 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (20% > lactate threshold)
Number of subjects: 22
Study 32300362 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (35% < lactate threshold)
Number of subjects: 22
Study 35850126 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of casirivimab and imdevimab
Number of subjects: 0
Study 35850126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32203207 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab (T) + Lapatinib (L)
Number of subjects: 4190
Study 32203207 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab (T)
Number of subjects: 4190
Study 32203207 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 4190
Study 35672756 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous peroneal nerve stimulator (tPNS) during gait training for 3 weeks
Number of subjects: 31
Study 35672756 — intervention group
Group type: COMPARATOR
Intervention: Conventional home and/or community gait training therapy (CT) for 3 weeks
Number of subjects: 31
Study 32289283 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 sessions of systemic cryostimulation at -120°C for 2-3 min
Number of subjects: 21
Study 35970655 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 151
Study 35970655 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel Positive Airway Pressure (BPAP)
Number of subjects: 151
Study 35970655 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 151
Study 33452180 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept monotherapy
Number of subjects: 0
Study 33452180 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX + Etanercept combination therapy
Number of subjects: 0
Study 33452180 — intervention group
Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 0
Study 32715946 — intervention group
Group type: EXPERIMENTAL
Intervention: New prediction models developed from VO2peak using 20 m-SR
Number of subjects: 148
Study 32715946 — intervention group
Group type: EXPERIMENTAL
Intervention: Model with BMI-z for girls
Number of subjects: 148
Study 32715946 — intervention group
Group type: EXPERIMENTAL
Intervention: Model with BMI-z and %FM for boys
Number of subjects: 148
Study 35860183 — intervention group
Group type: EXPERIMENTAL
Intervention: Algoplaque hydrocolloid dressing (AHD) combined with nanosilver antibacterial gel
Number of subjects: 100
Study 35860183 — intervention group
Group type: COMPARATOR
Intervention: Gauzes (Control)
Number of subjects: 100
Study 32983558 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretically informed physical activity intervention
Number of subjects: 20
Study 32286686 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (25 mg orally twice daily from days 8-12) + Clomiphene citrate (100 mg once daily from days 3-7)
Number of subjects: 80
Study 32286686 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (100 mg once daily from days 3-7)
Number of subjects: 80
Study 35725945 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 192
Study 35725945 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 192
Study 35725945 — intervention group
Group type: EXPERIMENTAL
Intervention: All-cause mortality
Number of subjects: 192
Study 35725945 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 192
Study 33485455 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (1000 mg infusions at 2-week intervals)
Number of subjects: 164
Study 33485455 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg infusions at 4-week intervals)
Number of subjects: 164
Study 33485455 — intervention group
Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 164
Study 33485455 — intervention group
Group type: COMPARATOR
Intervention: Tocilizumab
Number of subjects: 164
Study 33738615 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture tele-therapy in addition to methotrexate and aerobic exercise training (group A)
Number of subjects: 60
Study 33738615 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate and aerobic exercise training (group B)
Number of subjects: 60
Study 32757272 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Muscle Vibration (LMV)
Number of subjects: 75
Study 32757272 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV)
Number of subjects: 75
Study 32757272 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study 36272125 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-kHz spinal cord stimulation (SCS)
Number of subjects: 159
Study 36272125 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical management (CMM)
Number of subjects: 159
Study 36272125 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-kHz spinal cord stimulation (SCS) post-crossover
Number of subjects: 159
Study 34510104 — intervention group
Group type: EXPERIMENTAL
Intervention: Group medical visits with medication management plus low carbohydrate diet-focused weight management (WM/GMV; n=127)
Number of subjects: 263
Study 34510104 — intervention group
Group type: COMPARATOR
Intervention: Group medical visits with medication management alone (GMV; n=136)
Number of subjects: 263
Study 36102618 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung Volume Recruitment (LVR), used twice-daily as part of a randomized controlled trial
Number of subjects: 11
Study 36102618 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung Volume Recruitment (LVR)
Number of subjects: 11
Study 32504880 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRI-exposed children
Number of subjects: 111
Study 32504880 — intervention group
Group type: COMPARATOR
Intervention: Non-SSRI-exposed children
Number of subjects: 111
Study 36361362 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based exercise
Number of subjects: 0
Study 36361362 — intervention group
Group type: EXPERIMENTAL
Intervention: Land-based exercise
Number of subjects: 0
Study 36361362 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 0
Study 33328395 — intervention group
Group type: COMPARATOR
Intervention: ClearfilTM SE Bond 2 (SE, control)
Number of subjects: 96
Study 33328395 — intervention group
Group type: EXPERIMENTAL
Intervention: ClearfilTM Universal Bond (CU)
Number of subjects: 96
Study 33328395 — intervention group
Group type: EXPERIMENTAL
Intervention: ScotchBondTM Universal Adhesive (SB)
Number of subjects: 96
Study 33328395 — intervention group
Group type: EXPERIMENTAL
Intervention: RDT
Number of subjects: 96
Study 33328395 — intervention group
Group type: EXPERIMENTAL
Intervention: Smear layer types
Number of subjects: 96